Consumer Issues
Diesel, LPG prices not to go up as government fights political battle

Diesel, domestic LPG and kerosene rates, have not been revised since June last year and under current circumstances it does not look feasible for the UPA government to increase prices

New Delhi: Diesel and cooking gas (liquefied petroleum gas or LPG) prices are unlikely to be hiked even after the end of the Monsoon Session of Parliament next week as the government is wary of taking such a decision at a time when it already has political battles on hand, reports PTI.
Diesel, domestic LPG and kerosene rates, which have not been revised since June last year, were expected to be raised after the Parliament session ends on 7th September.
"It is extremely difficult under present circumstances to raise fuel prices," a top government source said here. "I am not saying that it is impossible but it certainly does not look feasible at this moment of time".
Even a hike in prices of petrol, a fuel which was freed from government control in June 2010, would be "difficult," he said.
State-run oil marketing companies are losing Rs3.85 per litre on sale of petrol as global oil prices have firmed up since the last revision in July. Petrol price were last hiked by Rs0.70 a litre on 24th July. It currently costs Rs68.46 per litre in Delhi and OMCs were hoping to be able to raise rates once Parliament session ends next week.
The government has been in fire-fighting mode since the time Comptroller and Auditor General (CAG) in a report stated that undue benefit of about Rs1.86 lakh crore was extended to private firms by allocating coal blocks for free since 2004.
The source said while state-owned oil firms are empowered to revise petrol prices, a decision on diesel, domestic LPG and kerosene rates has to be taken by the Cabinet Committee on Political Affairs (CCPA).
Oil companies are losing Rs450 crore per day on selling diesel at prices that are Rs15.55 a litre lower than its cost, kerosene at a discount of Rs29.97 a litre and under selling of Rs231 per 14.2-kg LPG cylinder.
Oil Minister S Jaipal Reddy hinted of Government's desire to make up for the losses incurred by OMCs instead of raising prices when he told Lok Sabha in a written reply that he has sought reduction in excise duty on petrol.

"In order to offset the under-recovery (loss) on petrol, Ministry of Petroleum and Natural Gas has taken up the matter with the Ministry of Finance for bringing down the incidence of excise duty," he said.

The government levies Rs14.78 a litre excise duty on petrol and it can be lowered in proportion to the losses oil firms incur currently.

"In order to mitigate losses on sale of petrol, oil marketing companies had, inter alia, suggested to the government to either declare petrol as a 'regulated' product temporarily and provide cash compensation for the under- recovery or reduce the excise duty on petrol from Rs14.78 per litre by an amount equivalent to the under-recovery on petrol," he said.

Not raising prices would mean the government will have to shell out a massive cash subsidy this fiscal to make up losses incurred by state-owned oil firms on sale of diesel, domestic LPG and kerosene. At current rate, the three PSU firms may end the fiscal with a record revenue loss of Rs167 lakh crore.

Indian Oil Corp, Bharat Petroleum Corp and Hindustan Petroleum Corp lost Rs47,811 crore on sale of the three controlled products during the April-June quarter. Of this, about Rs15,000 crore was made good by upstream firms. The remaining was to be compensated by the government by way of cash subsidy but that hasn't come so far.

In the absence of the subsidy support, IOC reported the highest quarterly net loss by any Indian company at Rs22,451 crore. HPCL posted Rs9,249 crore net loss in April-June while BPCL reported a net loss of Rs8,836 crore.

During 2011-12, the three oil marketing companies lost Rs1.38 lakh crore in revenue on selling diesel, LPG and kerosene at government controlled rates. To make up, the Government gave Rs83,500 crore in cash assistance, while upstream firms like Oil and Natural Gas Corp chipped in Rs55,000 crore.

This fiscal, the government may have to give a record Rs1 lakh crore in cash subsidy, sources said.



Om Prakash

5 years ago

It has been stated that the situation called for a Rs. 17/- per liter hike for DIESEL but AS A MERCY CONSIDERATION TO AAM AADMAI only Rs. 5/- has been loaded. Can any one publicise the PRICE BREAK UP of the Product to AAM AADMI. What are the components? How does the PROCESSING COST PER LITER COMPARE WITH INTERNATIONAL STANDARDS. HOW DOES EXCISE Etc. LEVIES COMPARE TO INTERNATIONAL AVERAGES?

Clinical trial process to be further streamlined: Government

According to the Health Minister, the proposed Committee of Experts would give its recommendations for compensation in case of injury or death during clinical trials to the DCGI to decide the final amount within three months

New Delhi: Procedures for clinical trials in India will be further streamlined and a panel of experts set up to analyse the cause of injury or death and to recommend quantum of compensation to victims, the Government said on Thursday, reports PTI.
Replying to a Calling Attention Motion on the issue in Rajya Sabha, Health and Family Welfare Minister Ghulam Nabi Azad said the government proposed to strengthen the rules by incorporating certain new provisions soon.
He said the proposed Committee of Experts would give its recommendations for compensation in case of injury or death during clinical trials to the Drug Controller of India (DCGI), to decide the final amount within three months.
The Minister said the proposals include that "in case of injury, the sponsor will provide medical care to the person concerned as long as required" and "there would be specific provision in Rules for payment of compensation to the affected persons/their nominees for trial related injuries/death".
Azad said the investigator shall report all serious adverse events, including death, to the DCGI as well as sponsor company and Ethics Committee within 24 hours of occurrence.
The Minister also assured the members that the government was seized of the sensitive matter and was taking steps to further streamline the procedure for clinical trials.
He said as per available data, the number of Serious Adverse Events (SAEs) of deaths in clinical trials reported during 2010, 2011 and up to June 2012 are 668, 438 and 211 respectively. He, however, said the SAEs of death due to clinical trials were 22 and 16 in 2010 and 2011 respectively.
During the discussion initiated by P Rajeeve (CPI-M), members expressed concern over the increased deaths during such trials.
Azad said the government proposed to modify the Informed Consent Form to include the socio-economic background of the person participating in the drug trial and his/her nominee's address. Requirements and guidelines for registration of Ethics Committee would also be prescribed in the rules.
Noting that death during clinical trials has been taken very seriously by the Government, he said, "The Government has taken concrete steps to strengthen the approval procedures, monitoring mechanism for clinical trials as well as to ensure that safety, rights and well-being of persons participating in clinical trials are protected.
Azad said a number of measures have already been taken for streamlining the procedure for clinical trials including making registration of clinical trials in ICMR registry mandatory since 15 June 2009.
He said among the measures taken include setting up of 12 new Drug Advisory Committees comprising leading experts to advise the Central Drugs Standard Control Organization (CDSCO) in matters relating to approval of clinical trials and new drugs.
Six Medical Device Advisory Committees have been set up by the government and a general experts pool for medical device advisory committees has also been set up, he said.
Besides, applications of investigational new drugs (IND) which have never been earlier used on human beings are also being evaluated by the IND committee chaired by the Director General, Indian Council of Medical Research.
Azad said every approval for conducting clinical trials now includes a condition that in case of study related injury or death, applicant will provide complete medical care as well as compensation and statement to this effect should be incorporated in the consent form.


Fixed Deposits: Premature repayment of deposits

Premature withdrawal by the survivor from joint fixed deposits is now possible, in case of...

Premium Content
Monthly Digital Access


Already A Subscriber?
Yearly Digital+Print Access


Moneylife Magazine Subscriber or MSSN member?

Yearly Subscriber Login

Enter the mail id that you want to use & click on Go. We will send you a link to your email for verficiation

We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)